Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 376,837,792
  • Shares Outstanding, K 2,406,679
  • Annual Sales, $ 85,159 M
  • Annual Income, $ 35,153 M
  • 60-Month Beta 0.52
  • Price/Sales 4.27
  • Price/Cash Flow 10.92
  • Price/Book 5.13
Trade JNJ with:

Options Overview Details

View History
  • Implied Volatility 15.57% ( -0.96%)
  • Historical Volatility 14.77%
  • IV Percentile 32%
  • IV Rank 31.57%
  • IV High 22.17% on 10/03/23
  • IV Low 12.53% on 05/09/24
  • Put/Call Vol Ratio 0.39
  • Today's Volume 38,505
  • Volume Avg (30-Day) 36,627
  • Put/Call OI Ratio 0.70
  • Today's Open Interest 401,078
  • Open Int (30-Day) 335,296

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 20 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 2.71
  • Number of Estimates 7
  • High Estimate 2.74
  • Low Estimate 2.68
  • Prior Year 2.80
  • Growth Rate Est. (year over year) -3.21%

Price Performance

See More
Period Period Low Period High Performance
1-Month
144.50 +8.47%
on 07/05/24
157.49 -0.47%
on 07/17/24
+11.10 (+7.62%)
since 06/18/24
3-Month
143.71 +9.07%
on 05/29/24
157.49 -0.47%
on 07/17/24
+11.00 (+7.55%)
since 04/18/24
52-Week
143.13 +9.51%
on 04/18/24
175.97 -10.93%
on 08/10/23
-2.32 (-1.46%)
since 07/18/23

Most Recent Stories

More News
A Top-Tier Dividend Stock Every Passive-Income Investor Should Consider

This healthcare behemoth is one of the best dividend stocks on the planet.

V : 270.13 (-0.94%)
SPGI : 488.41 (-0.30%)
JNJ : 156.85 (+0.17%)
Is Johnson & Johnson a Buy Now?

Second-quarter results suggest the spinoff of the company's slow-growing consumer goods segment is having the intended effect.

JNJ : 156.85 (+0.17%)
Stocks Rise Before the Open as Tech Steadies, Netflix Earnings and ECB Decision in Focus

September S&P 500 E-Mini futures (ESU24) are up +0.18%, and September Nasdaq 100 E-Mini futures (NQU24) are up +0.41% this morning, signaling a partial rebound from yesterday’s slump, while investors...

ESU24 : 5,613.00 (-0.46%)
NQU24 : 19,919.00 (-0.39%)
SAVE : 2.78 (-1.42%)
ASML : 917.14 (-1.60%)
AMD : 154.79 (-2.91%)
NVDA : 119.71 (+1.46%)
FIVE : 72.01 (-5.87%)
JNJ : 156.85 (+0.17%)
NFLX : 644.32 (-0.48%)
ABT : 100.91 (-3.60%)
BX : 138.57 (+2.76%)
ISRG : 415.30 (-2.56%)
2 Magnificent S&P 500 Dividend Stocks Down 19% and 41% to Buy and Hold Forever

The market can be unpredictable in the short run, but over the long term, the best companies will build lasting wealth for their shareholders.

SBUX : 74.57 (-0.71%)
JNJ : 156.85 (+0.17%)
Johnson & Johnson’s Q2 Profit Beats Forecasts on Drug Sales

Johnson & Johnson (JNJ) beat estimates for second-quarter profit and revenue on Wednesday, driven by strong sales of its drugs, including cancer treatment Darzalex and blockbuster psoriasis drug Stelara....

JNJ : 156.85 (+0.17%)
ABT : 100.91 (-3.60%)
SYK : 331.59 (-0.91%)
MDT : 81.63 (+0.46%)
Why Johnson & Johnson Stock Was a Winner on Wednesday

The company did a fine job of boosting sales of numerous drugs.

JNJ : 156.85 (+0.17%)
Broader Market Closes Lower as Chip Stocks Plunge

The S&P 500 Index ($SPX ) (SPY ) Wednesday closed down -1.39%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.59%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -2.94%. Stock indexes...

$SPX : 5,561.01 (-0.49%)
SPY : 553.57 (-0.61%)
$DOWI : 40,935.50 (-0.64%)
DIA : 408.57 (-0.82%)
$IUXX : 19,711.91 (-0.44%)
QQQ : 478.90 (-0.60%)
ZNU24 : 111-080 (-0.17%)
ASML : 917.14 (-1.60%)
AMD : 154.79 (-2.91%)
AMAT : 215.56 (-2.05%)
MRVL : 66.63 (-1.91%)
LRCX : 941.00 (-2.76%)
Johnson & Johnson (JNJ) Q2 2024 Earnings Call Transcript

JNJ earnings call for the period ending June 30, 2024.

JNJ : 156.85 (+0.17%)
Broader Market Slides as Chip Stocks Plunge

The S&P 500 Index ($SPX ) (SPY ) today is down -1.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.26%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.29%. Stock indexes today are mixed,...

$SPX : 5,561.01 (-0.49%)
SPY : 553.57 (-0.61%)
$DOWI : 40,935.50 (-0.64%)
DIA : 408.57 (-0.82%)
$IUXX : 19,711.91 (-0.44%)
QQQ : 478.90 (-0.60%)
ZNU24 : 111-080 (-0.17%)
ASML : 917.14 (-1.60%)
AMD : 154.79 (-2.91%)
AMAT : 215.56 (-2.05%)
LRCX : 941.00 (-2.76%)
MRVL : 66.63 (-1.91%)
Johnson & Johnson’s Financial Results Beat On Top And Bottom Lines

Pharmaceutical giant Johnson & Johnson’s (JNJ) second-quarter financial results beat Wall Street forecasts ...

JNJ : 156.85 (+0.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among...

See More

Key Turning Points

3rd Resistance Point 164.98
2nd Resistance Point 161.24
1st Resistance Point 158.91
Last Price 156.85
1st Support Level 152.83
2nd Support Level 149.09
3rd Support Level 146.76

See More

52-Week High 175.97
Fibonacci 61.8% 163.43
Fibonacci 50% 159.55
Last Price 156.85
Fibonacci 38.2% 155.67
52-Week Low 143.13

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar